Amgen adds former Yum! Brands CEO David W. Gibbs to its board
Amgen's board appointed David W. Gibbs as a director on October 26, 2026. Before that, he was CEO of Yum! Brands until September 2025.
Key points
- Amgen's board appointed David W. Gibbs as a director, effective immediately.
- Chairman and CEO Robert A. Bradway said Gibbs's experience creating direct relationships with customers will help the company prepare for future launches.
- The filings give no financial impact of the appointment on Amgen.
What happened
Amgen's board appointed David W. Gibbs as a director, effective immediately. He will join the Audit Committee and the Compensation and Management Development Committee. After the appointment, the board will have 13 directors, 12 of whom are independent.
Gibbs was chief executive of Yum! Brands from 2020 to September 2025. The company says he recently retired from that role.
What the appointment changes
- EventAmgen's board appointed David W. Gibbs as a director
- What changesHe will join the Audit Committee and the Compensation and Management Development Committee
- Who it matters toAfter the appointment, the board will have 13 directors, 12 of whom are independent
What the company says
Chairman and CEO Robert A. Bradway said Gibbs's experience creating direct relationships with customers will help the company prepare for future launches.
What this change does not mean
The filings give no financial impact of the appointment on Amgen.
Gibbs's experience is the company's explanation, not a result. It does not show changes in sales or profit.
Original sources
Cite this article
The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.
Follow Amgen
A notification in your browser or on your phone when we publish about Amgen. Free, no email, no account, no app.
Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards
